Lung cancer in women: Clinical features and factors related to survival;Kadinlarda akciǧer kanseri: Klinik özellikler ve saǧkalima etkili faktörler

Tuberkuloz ve Toraks

Volumn 56, Issue 3, 2008, Pages 266-274

  Şen, Elif ^a,b   Kaya, Akin ^a   Erol, Serhat ^a   Savaş, Ismail ^a   Gönüllü, Uǧur ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Prognostic factors; Survival; Women lung cancer

Indexed keywords

ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BRONCHOSCOPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DYSPNEA; ELECTROCORTICOGRAPHY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG CARCINOID CANCER; LUNG LOBE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PROGNOSIS; RELATIVE; SMOKING; SURVIVAL TIME; THORAX PAIN; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS; TURKEY;

EID: 55049124981     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: Epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 2007; 55: 15-23.
2. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. Cancer J Clin 2007; 57: 43-66.
3. İtil O. Akciǧer kanserlerinin epidemiyolojisi ve etyolojisi. Haydaroǧlu A (editör). Akciǧer Kanserleri: Tani ve Tedavi. ?zmir: Ege Üniversitesi Basimevi, 2000: 15-34.
4. The Ministry of Health Department of Cancer Control. Cancer Control Programme and Cancer Statistics in Turkey (1995-1999). Ankara 2002: 135-61.
5. Fidaner C, Eser SY, Parkin DM. Incidence in Izmir in 1993-1994: First results from Izmir Cancer Registry. Eur J Cancer 2001; 37: 83-92.
6. Goksel T, Akkoclu A; Turkish Thoracic Society, Lung and Pleural Malignancies Study Group. Pattern of lung cancer in Turkey, 1994-1998. Respiration 2002; 69: 207-10.
7. Risch HA, Howe GR, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analisys by histological type. Am J Epidemiol 1993; 138: 281-93.
8. Bain C, Feskanich D, Speizer F, et al. Lung cancer rates in men and women comparable histories of smoking. J Natl Cancer Inst 2004; 96: 826-34.
9. Novello S, Baldini E. Women and lung cancer. Ann Oncol 2006; 17(Supp 2): 79-82.
10. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002; 13: 1087-93.
11. Patel JD, Bach PB, Kris MG. Lung cancer in US women, a contemporary epidemic. JAMA 2004; 291: 1763-8.
12. Thomas L, Doyle A, Edelman MJ. Lung cancer in women, emerging differences in epidemiology, biology and therapy. Chest 2005; 128: 370-81.
13. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982; 5: 649-55.
14. World Health Organization. Histological typing of lung and pleural tumors. World Health Organization, Copenhagen, 1999.
15. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-7.
16. Fu JB, Ying Kau T, Severson RK, Kalemkerian GP. Lung cancer in women, analysis of the national surveillance, epidemiology, and end results database. Chest 2005; 127: 768-77.
17. Utkaner G, Yilmaz U, C¸elikten E, Gürsoy M. Primer akciǧer kanserli 116 kadin olgunun analizi. Solunum Hastaliklari 1996; 7: 1-9.
18. Yurdakul A, Çalişir H, Demiraǧ F ve ark. Akciǧer kanserinin histolojik tiplerinin daǧilimi. Toraks Dergisi 2002; 3: 59-65.
19. Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: Epidemiology, prevention, and early detection. Lancet Oncology 2003; 4: 45-55.
20. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: Examination of the evidence. J Natl Cancer Inst 1996; 88: 183-92.
21. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315: 980-8.
22. Fontham ET, Correa P, Reynolds P, et al. Environmental tobacco smoke and lung cancer in nonsmoking women: A multicenter study. JAMA 1994; 271: 1752-9.
23. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 1996; 144: 554-62.
24. Wu AF, Fontham ET, Reynolds P, et al. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1996; 143: 535-42.
25. Alavanja MCR, Browson RC, Boice JD, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992; 136: 623-32.
26. Blanchon F, Grivaux M, Collon T, et al. Epidemiologic of primary bronchial carcinoma management in the general French hospital centers. Rev Mal Respir 2002; 19: 727-34.
27. Charcioux A, Rossignol M, Purohit A, et al. International differences in epidemiology of lung adenocarcinoma. Lung Cancer 1997; 16: 133-43.
28. Muscat JE, Wynder EL. Lung cancer pathology in smokers, ex-smokers and never smokers. Cancer Lett 1995; 88: 1-5.
29. Stellman SD, Muscat JE, Thompson S, et al. Risk of squamous cell carcinoma and adenocarcinoma of lung in relation to lifetime filter cigarette smoking. Cancer 1997; 80: 382-8.
30. Köktu¨rk N, Yeǧin D, C¸iftçi Ulukavak T ve ark. Akciǧer kanserlerinde epidemiyolojik özellikler yillar ic¸inde deǧişim gösteriyor mu? Toraks Dergisi 2004; 5: 137-42.
31. Bozkurt B, Selçuk ZT, Firat P ve ark. 1972-2005 döneminde Hacettepe Üniversitesi Tip Fakültesi Hastanesi'nde akciǧer kanseri tanisi konulan hastalarin histolojik ve epidemiyolojik deǧerlendirmesi. Toraks Dergisi 2004; 5: 148-53.
32. Çelikoǧlu SI, Aykan TB, Karyel T. Bronchoscopic findings: Review of 345 cases. Respiration 1986; 49: 132-6.
33. Wakelee HA, Wang W, Schiller JH, et al. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol 2006; 1: 441-6.
34. Singh S, Parulekar W, Murray N, et al. Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol 2005; 23: 850-6.
35. Johnson BE, Steinberg SM, Phelps R, et al. Female patients with small cell lung cancer live longer than male patients. Am J Med 1988; 85: 194-6.
36. Ginsberg RJ, Vokes EE, Rosenweig K. Non-small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer Principles and Practice of Oncology. 6th ed. Lippincott Williams and Wilkins, 2001: 925-83.
37. Siegel Lakhai WS, Beijenen JH, Schellens JH. Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa). Oncologist 2005; 10: 579-89.
38. Bell DW, Lynch TJ, Haserlat SM, et al. Epidermal growth factor receptor mutations and gene amplification in non small cell lung cancer: Molecular analysis of IDEAL/INTACT gefitinib trials. J Clin Oncol 2005; 23: 8081-92.